SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Antimicrob Agents Chemother. 2015;59(9):5413-9.

Interactions between QnrB, QnrB mutants, and DNA gyrase.

, , , , , , ,

제1저자 김의석 · 교신저자 David C. Hooper

소속 (7)
  1. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  2. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA Institute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, National Health and Family Planning Commission, Shanghai, China.
  3. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
  4. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  5. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA Biological Research Laboratories, Daiichi Sankyo Co. Ltd., Tokyo, Japan.
  6. Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
  7. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA dhooper@mgh.harvard.edu.

Abstract

Plasmid-encoded protein QnrB1 protects DNA gyrase from ciprofloxacin inhibition. Using a bacterial two-hybrid system, we evaluated the physical interactions between wild-type and mutant QnrB1, the GyrA and GyrB gyrase subunits, and a GyrBA fusion protein. The interaction of QnrB1 with GyrB and GyrBA was approximately 10-fold higher than that with GyrA, suggesting that domains of GyrB are important for stabilizing QnrB1 interaction with the holoenzyme. Sub-MICs of ciprofloxacin or nalidixic acid reduced the interactions between QnrB1 and GyrA or GyrBA but produced no reduction in the interaction with GyrB or a quinolone-resistant GyrA:S83L (GyrA with S83L substitution) mutant, suggesting that quinolones and QnrB1 compete for binding to gyrase. Of QnrB1 mutants that reduced quinolone resistance, deletions in the C or N terminus of QnrB1 resulted in a marked decrease in interactions with GyrA but limited or no effect on interactions with GyrB and an intermediate effect on interactions with GyrBA. While deletion of loop B and both loops moderately reduced the interaction signal with GyrA, deletion of loop A resulted in only a small reduction in the interaction with GyrB. The loop A deletion also caused a substantial reduction in interaction with GyrBA, with little effect of loop B and dual-loop deletions. Single-amino-acid loop mutations had little effect on physical interactions except for a Δ105I mutant. Therefore, loops A and B may play key roles in the proper positioning of QnrB1 rather than as determinants of the physical interaction of QnrB1 with gyrase.

Copyright © 2015, American Society for Microbiology. All Rights Reserved.

그 밖의 정보
출판 형태
Journal Article, Research Support, N.I.H., Extramural
저널
Antimicrobial agents and chemotherapy · eISSN 1098-6596
전자 출판
2015-06-22
MeSH
DNA Gyrase / genetics / metabolism · Escherichia coli / genetics / metabolism · Escherichia coli Proteins / genetics / metabolism · Protein Binding · Two-Hybrid System Techniques
Substances
Escherichia coli Proteins · Qnr protein, E coli · DNA Gyrase
연구비
NIAID NIH HHS R01 AI057576
참고문헌
32편